State Of Wyoming Puma Biotechnology, Inc. Transaction History

State Of Wyoming

$826 Million
Q3 2025

A detailed history of State Of Wyoming transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, State Of Wyoming holds 12,737 shares of PBYI stock, worth $63,048. This represents 0.01% of its overall portfolio holdings.

Number of Shares

12,737

Holding current value

$63,048

% of portfolio

0.01%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 04, 2025	BUY	$3.07 - $5.73 $39,102 - $72,983	12,737 New	12,737 $65,000
Q4 2024 Feb 14, 2025	SELL	$2.42 - $3.39 $127,422 - $178,497	-52,654 Reduced 72.05%	20,426 $62,000
Q3 2024 Nov 14, 2024	BUY	$2.25 - $4.03 $103,763 - $185,851	46,117 Added 171.04%	73,080 $186,000
Q2 2024 Aug 14, 2024	BUY	$2.92 - $5.83 $59,313 - $118,424	20,313 Added 305.46%	26,963 $87,000
Q1 2024 May 13, 2024	BUY	$4.29 - $7.4 $28,528 - $49,210	6,650 New	6,650 $35,000

Q2 2022 Aug 15, 2022	SELL	$1.64 - $3.3 $41,121 - $82,744	-25,074 Reduced 54.74%	20,732 $59,000
Q1 2022 May 13, 2022	BUY	$2.13 - $3.24 $9,127 - $13,883	4,285 Added 10.32%	45,806 $132,000
Q4 2021 Feb 11, 2022	BUY	$2.85 - $6.58 $107,781 - $248,842	37,818 Added 1021.28%	41,521 $126,000
Q3 2021 Feb 11, 2022	SELL	$6.63 - $9.39 $251 - $356	-38 Reduced 1.02%	3,703 $26,000
Q2 2021 Feb 11, 2022	BUY	$8.98 - $11.6 $33,594 - $43,395	3,741 New	3,741 $34,000

Others Institutions Holding PBYI

# of Institutions

135

Shares Held

35.2M

Call Options Held

264K

Put Options Held

Acorn Capital Advisors, LLC New York, NY

4.13M
Shares

$20.4 Million
11.14% of portfolio
Vanguard Group Inc Valley Forge, PA

3.69M
Shares

$18.3 Million
0.0% of portfolio
Black Rock Inc. New York, NY

3.57M
Shares

$17.7 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

2.15M
Shares

$10.6 Million
0.02% of portfolio
Acadian Asset Management LLC Boston, MA

2.05M
Shares

$10.2 Million
0.02% of portfolio

View Full List

About PUMA BIOTECHNOLOGY, INC.

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $226M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

More about PBYI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.

Account